BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 23386286)

  • 1. Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways.
    Zhang Z; Li S; Cui M; Gao X; Sun D; Qin X; Narsinh K; Li C; Jia H; Li C; Han Y; Wang H; Cao F
    Basic Res Cardiol; 2013 Mar; 108(2):333. PubMed ID: 23386286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction.
    Zhang Z; Liang D; Gao X; Zhao C; Qin X; Xu Y; Su T; Sun D; Li W; Wang H; Liu B; Cao F
    Basic Res Cardiol; 2014 Jul; 109(4):417. PubMed ID: 24847908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ghrelin improves functional survival of engrafted adipose-derived mesenchymal stem cells in ischemic heart through PI3K/Akt signaling pathway.
    Han D; Huang W; Ma S; Chen J; Gao L; Liu T; Zhang R; Li X; Li C; Fan M; Chen Y; Cao F
    Biomed Res Int; 2015; 2015():858349. PubMed ID: 25879037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2.
    Xu R; Chen J; Cong X; Hu S; Chen X
    J Cell Biochem; 2008 Jan; 103(1):256-69. PubMed ID: 17497701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of NRG1-ERBB4 signaling potentiates mesenchymal stem cell-mediated myocardial repairs following myocardial infarction.
    Liang X; Ding Y; Zhang Y; Chai YH; He J; Chiu SM; Gao F; Tse HF; Lian Q
    Cell Death Dis; 2015 May; 6(5):e1765. PubMed ID: 25996292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy mediates the beneficial effect of hypoxic preconditioning on bone marrow mesenchymal stem cells for the therapy of myocardial infarction.
    Zhang Z; Yang C; Shen M; Yang M; Jin Z; Ding L; Jiang W; Yang J; Chen H; Cao F; Hu T
    Stem Cell Res Ther; 2017 Apr; 8(1):89. PubMed ID: 28420436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finasteride as a potential tool to improve mesenchymal stem cell transplantation for myocardial infarction.
    Sharifi AM; Mottaghi S
    Med Hypotheses; 2012 Apr; 78(4):465-7. PubMed ID: 22289340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of combined treatment with rosuvastatin and protein kinase Cβ2 inhibitor on angiogenesis following myocardial infarction in diabetic rats.
    Huang D; Wang FB; Guo M; Li S; Yan ML; Yu T; Wei M; Li JB
    Int J Mol Med; 2015 Mar; 35(3):829-38. PubMed ID: 25524396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of insulin-like growth factor 1 exerts a protective effect on hypoxic injury of aged BM-MSCs: role of autophagy.
    Yang M; Wen T; Chen H; Deng J; Yang C; Zhang Z
    Stem Cell Res Ther; 2018 Oct; 9(1):284. PubMed ID: 30359321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide releasing hydrogel enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction.
    Yao X; Liu Y; Gao J; Yang L; Mao D; Stefanitsch C; Li Y; Zhang J; Ou L; Kong D; Zhao Q; Li Z
    Biomaterials; 2015 Aug; 60():130-40. PubMed ID: 25988728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine 1-phosphate promotes mesenchymal stem cell-mediated cardioprotection against myocardial infarction via ERK1/2-MMP-9 and Akt signaling axis.
    Chen R; Cai X; Liu J; Bai B; Li X
    Life Sci; 2018 Dec; 215():31-42. PubMed ID: 30367841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin facilitates adipose-derived mesenchymal stem cells to repair the murine infarcted heart via the SIRT1 signaling pathway.
    Han D; Huang W; Li X; Gao L; Su T; Li X; Ma S; Liu T; Li C; Chen J; Gao E; Cao F
    J Pineal Res; 2016 Mar; 60(2):178-92. PubMed ID: 26607398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosuvastatin treatment activates JAK-STAT pathway and increases efficacy of allogeneic mesenchymal stem cell transplantation in infarcted hearts.
    Xu H; Yang YJ; Qian HY; Tang YD; Wang H; Zhang Q
    Circ J; 2011; 75(6):1476-85. PubMed ID: 21502705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of RISK by HMG-CoA reductase inhibition affords cardioprotection after myocardial infarction.
    Vilahur G; Casaní L; Peña E; Duran X; Juan-Babot O; Badimon L
    Atherosclerosis; 2009 Sep; 206(1):95-101. PubMed ID: 19419716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow-derived mesenchymal stem cells enhance autophagy via PI3K/AKT signalling to reduce the severity of ischaemia/reperfusion-induced lung injury.
    Li J; Zhou J; Zhang D; Song Y; She J; Bai C
    J Cell Mol Med; 2015 Oct; 19(10):2341-51. PubMed ID: 26177266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model.
    Lim SY; Kim YS; Ahn Y; Jeong MH; Hong MH; Joo SY; Nam KI; Cho JG; Kang PM; Park JC
    Cardiovasc Res; 2006 Jun; 70(3):530-42. PubMed ID: 16563361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
    Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
    Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of liver X receptor improves viability of adipose-derived mesenchymal stem cells to attenuate myocardial ischemia injury through TLR4/NF-κB and Keap-1/Nrf-2 signaling pathways.
    Wang Y; Li C; Cheng K; Zhang R; Narsinh K; Li S; Li X; Qin X; Zhang R; Li C; Su T; Chen J; Cao F
    Antioxid Redox Signal; 2014 Dec; 21(18):2543-57. PubMed ID: 24915051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of phosphoinositide-3-kinase class II alpha enhances mesenchymal stem cell survival in infarcted myocardium.
    Eun LY; Song BW; Cha MJ; Song H; Kim IK; Choi E; Chang W; Lim S; Choi EJ; Ham O; Lee SY; Byun KH; Jang Y; Hwang KC
    Biochem Biophys Res Commun; 2010 Nov; 402(2):272-9. PubMed ID: 20937252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ELABELA ameliorates hypoxic/ischemic-induced bone mesenchymal stem cell apoptosis via alleviation of mitochondrial dysfunction and activation of PI3K/AKT and ERK1/2 pathways.
    Fu J; Chen X; Liu X; Xu D; Yang H; Zeng C; Long H; Zhou C; Wu H; Zheng G; Wu H; Wang W; Wang T
    Stem Cell Res Ther; 2020 Dec; 11(1):541. PubMed ID: 33317626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.